Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Antibody EngineeringAntibody Engineering
Not Confirmed
Not Confirmed
15-19 December, 2024
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Not Confirmed
Not Confirmed
03-05 January, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
15-19 December, 2024
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
08 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/2024-ash-oral-presentationabbisko-presents-promising-preliminary-phase-2-study-results-of-pimicotinib-in-the-treatment-of-chronic-graft-versus-host-disease-cgvhd-at-the-66th-ash-annual-meeting-302325684.html
11 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/pimicotinib-significantly-improved-outcomes-for-patients-with-tenosynovial-giant-cell-tumor-in-a-global-phase-iii-trial-302301539.html
18 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/best-poster-of-esmo--2024-abbisko-announces-updated-clinical-data-of-irpagratinib-in-hcc-302251728.html
13 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/abbisko-therapeutics-announces-that-us-fda-has-granted-fast-track-designation-for-its-csf-1r-inhibitor-pimicotinib-absk021-302014220.html
04 Dec 2023
// BUSINESSWIRE
06 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/87-5-orr--abbisko-presented-two-clinical-updates-of-pimicotinib-at-the-2023-ctos-annual-meeting-301979448.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?